Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81Leukemia 41Gastrointestinal Stromal Tumors 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Leukemia, Myeloid, Chronic-Phase 27Blast Crisis 13Neoplasms 10Neoplasm Metastasis 10Melanoma 10Brain Neoplasms 10Lung Neoplasms 9Prostatic Neoplasms 8Leukemia, Myeloid, Acute 8Gliosarcoma 8Glioblastoma 8Leukemia, Myeloid, Accelerated Phase 7Glioma 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 5Philadelphia Chromosome 5Oligodendroglioma 5Recurrence 4Primary Myelofibrosis 4Polycythemia Vera 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 4Astrocytoma 4

Interventions

Surveys and Questionnaires 2Imatinib Mesylate 2talimogene laherparepvec 1pirfenidone 1nilotinib 1mirdametinib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neurofibromatoses × Imatinib Mesylate × Clear all
NCT01140360 2017-07-02

0908-09

Indiana University

Phase 1/2 Completed
21 enrolled 8 charts
CNS

Neurofibroma, Neurofibromatoses

NCT01673009 2016-04-06

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Indiana University

Phase 2 Completed
36 enrolled 8 charts
CNS

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡